ascopubs.org

Phenotyping Hepatic Immune-Related Adverse Events in the Setting of Immune Checkpoint Inhibitor Therapy

Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and Microsimulation We developed a set of criteria to ...
Medscape

Drug-Induced Liver Injury: What You Need to Know

Liver tests should be obtained in all patients with suspected DILI. Calculating the ratio of the alanine aminotransferase (ALT) value/ALT upper limit of normal (ULN) divided by the alkaline ...
Medscape

Hepatocellular Enzyme Elevations in a Patient Receiving Ceftriaxone

Our patient's AST value was 17 times the ULN, and his ALT level was 11 times the ULN. While this is considered clinically significant, it is unknown how often ceftriaxone induces such substantial ...

My LFT is slightly high, but I feel fine”: Doctors explain when borderline liver reports turn dangerous and what should be the immediate preventive measures

LFT slightly high. There is no pain. No yellowing of the eyes. No weakness. So it is easy to brush it aside. But the liver rarely shouts in the beginning. It whispers.Liver Function Tests, or LFTs, ...
ascopubs.org

Erratum: Phenotyping Hepatic Immune-Related Adverse Events in the Setting of Immune Checkpoint Inhibitor Therapy

The article by Feldman et al entitled “Phenotyping Hepatic Immune-Related Adverse Events in the Setting of Immune Checkpoint Inhibitor Therapy” (JCO Clinical ...